Literature DB >> 20145662

Pediatrics: combining antimuscarinics shows promise for overactive bladder.

Jean-Jacques Wyndaele.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20145662     DOI： 10.1038/nrurol.2010.1

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  9 in total

Review 1.  Muscarinic receptors of the urinary bladder: detrusor, urothelial and prejunctional.

Authors:  R Chess-Williams
Journal:  Auton Autacoid Pharmacol       Date:  2002-06

Review 2.  Role of the urothelium in urinary bladder dysfunction following spinal cord injury.

Authors:  Lori A Birder
Journal:  Prog Brain Res       Date:  2006       Impact factor: 2.453

3.  Neurogenic bladder treatment by doubling the recommended antimuscarinic dosage.

Authors:  M Horstmann; T Schaefer; Y Aguilar; A Stenzl; K D Sievert
Journal:  Neurourol Urodyn       Date:  2006       Impact factor: 2.696

4.  Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size.

Authors:  Claus G Roehrborn; Steven A Kaplan; J Stephen Jones; Joseph T Wang; Tamara Bavendam; Zhonghong Guan
Journal:  Eur Urol       Date:  2008-06-17       Impact factor: 20.096

5.  Double anticholinergic therapy for refractory overactive bladder.

Authors:  Stéphane Bolduc; Katherine Moore; Sylvie Lebel; Pascale Lamontagne; Micheline Hamel
Journal:  J Urol       Date:  2009-08-20       Impact factor: 7.450

6.  Combination drug therapy improves compliance of the neurogenic bladder.

Authors:  Anne P Cameron; J Quentin Clemens; Jerilyn M Latini; Edward J McGuire
Journal:  J Urol       Date:  2009-07-18       Impact factor: 7.450

Review 7.  Medicinal chemistry and therapeutic potential of muscarinic M3 antagonists.

Authors:  Ilaria Peretto; Paola Petrillo; Bruno P Imbimbo
Journal:  Med Res Rev       Date:  2009-11       Impact factor: 12.944

8.  Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder.

Authors:  Hsin-Tzu Liu; Michael B Chancellor; Hann-Chorng Kuo
Journal:  BJU Int       Date:  2009-02-11       Impact factor: 5.588

9.  Effective treatment of neurogenic detrusor dysfunction by combined high-dosed antimuscarinics without increased side-effects.

Authors:  Bastian Amend; Jörg Hennenlotter; Tobias Schäfer; Marcus Horstmann; Arnulf Stenzl; Karl-Dietrich Sievert
Journal:  Eur Urol       Date:  2008-01-17       Impact factor: 20.096
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.